2.Haemoglobin E-beta Thalassaemia in Singapore.
Ee Shien TAN ; Cedric KOH ; Hai Yang LAW ; Guek Peng TAN ; Angeline Hwei Meeng LAI ; Ivy Swee Lian NG
Annals of the Academy of Medicine, Singapore 2014;43(6):331-333
Adolescent
;
Adult
;
Child
;
Child, Preschool
;
Female
;
Hemoglobin E
;
analysis
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies
;
Severity of Illness Index
;
Singapore
;
Young Adult
;
beta-Thalassemia
;
blood
;
therapy
3.Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program.
Ivy H Y NG ; Kitty K T CHEUNG ; Tiffany T L YAU ; Elaine CHOW ; Risa OZAKI ; Juliana C N CHAN
Endocrinology and Metabolism 2018;33(1):17-32
The rapid increase in diabetes prevalence globally has contributed to large increases in health care expenditure on diabetic complications, posing a major health burden to countries worldwide. Asians are commonly observed to have poorer β-cell function and greater insulin resistance compared to the Caucasian population, which is attributed by their lower lean body mass and central obesity. This “double phenotype” as well as the rising prevalence of young onset diabetes in Asia has placed Asians with diabetes at high risk of cardiovascular and renal complications, with cancer emerging as an important cause of morbidity and mortality. The experience from Hong Kong had demonstrated that a multifaceted approach, involving team-based integrated care, information technological advances, and patient empowerment programs were able to reduce the incidence of diabetic complications, hospitalizations, and mortality. System change and public policies to enhance implementation of such programs may provide solutions to combat the burgeoning health problem of diabetes at a societal level.
Architectural Accessibility*
;
Asia
;
Asian Continental Ancestry Group
;
Delivery of Health Care
;
Diabetes Complications
;
Diabetes Mellitus, Type 2
;
Health Expenditures
;
Hong Kong*
;
Hospitalization
;
Humans
;
Incidence
;
Insulin Resistance
;
Mortality
;
Obesity, Abdominal
;
Patient Participation
;
Prevalence
;
Public Policy
4.Academy of Medicine-Ministry of Health clinical practice guidelines: attention deficit hyperactivity disorder.
Daniel S S FUNG ; Choon Guan LIM ; John Chee Meng WONG ; Koon Hock NG ; Christopher Cheng Soon CHEOK ; Jennifer Sie Hee KIING ; Shang Chee CHONG ; June LOU ; Mary Lourdes DANIEL ; Desmond ONG ; Charity LOW ; Sharifah Mariam ALJUNIED ; Pui Meng CHOI ; Kala MEHROTRA ; Carolyn KEE ; Ivy LEUNG ; Lee Chen YEN ; Geraldine WONG ; Poh Yin LEE ; Bella CHIN ; Hwee Chien NG
Singapore medical journal 2014;55(8):411-quiz 415
The Academy of Medicine (AMS) and the Ministry of Health (MOH) have developed the clinical practice guidelines on Attention Deficit Hyperactivity Disorder (ADHD) to provide doctors and patients in Singapore with evidence-based treatment for ADHD. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on ADHD, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html.The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Attention Deficit Disorder with Hyperactivity
;
diagnosis
;
drug therapy
;
therapy
;
Caregivers
;
Child
;
Evidence-Based Medicine
;
Humans
;
Methylphenidate
;
therapeutic use
;
Parents
;
Psychiatry
;
methods
;
standards
;
Singapore
;
Societies, Medical
5.Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Michelle Shu Fen TSENG ; Huili ZHENG ; Ivy Wei Shan NG ; Yiat Horng LEONG ; Cheng Nang LEONG ; Wei Peng YONG ; Wai Kit CHEONG ; Jeremy Chee Seong TEY
Singapore medical journal 2018;59(6):305-310
INTRODUCTIONNeoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision (TME) surgery for locally advanced rectal cancer has been shown to improve local control and reduce toxicity, as compared to adjuvant CRT. We reported the outcomes of our patients with locally advanced rectal cancer treated at National University Hospital, Singapore.
METHODSFrom April 2002 to December 2014, 117 patients with T3/4, N0/+, M0 rectal cancer received neoadjuvant CRT followed by TME surgery. The treatment regimen comprised a total radiotherapy dose of 50.4 Gy in 28 daily fractions delivered concurrently with 5-fluorouracil or capecitabine chemotherapy over 5.5 weeks. All patients were planned for TME surgery. Local control, disease-free survival, overall survival and treatment toxicities were analysed.
RESULTSMedian follow-up was 34 (range 2-122) months. 11.5% (13/113) of patients achieved a pathological complete response (pCR) and 72.6% (85/117) had either tumour or nodal downstaging following neoadjuvant CRT. 5.2% (5/96) of patients had Grade 3 acute toxicities (dermatitis and diarrhoea) and 3.1% (3/96) had Grade 3 late toxicities (fistula and stricture). There was no Grade 4 toxicity noted. The five-year local recurrence, disease-free survival and overall survival rates were 4.5%, 65.7% and 80.6%, respectively. Multivariate analysis showed that nodal positivity was a predictor of poor disease-free survival and poor overall survival. Tumour downstaging and pCR did not improve outcomes.
CONCLUSIONOur outcomes were comparable to internationally published data, and this treatment regimen remains the standard of care for locally advanced rectal cancer in our local population.
6.Proposed new retinopathy of prematurity screening criteria: Evidence for including older and heavier Filipino premature babies
Kristine Corpus ; Jose Melvin Jimenez IV ; Rachelle Anzures ; Rena Ivy Bascuna ; Ricardo Ventura ; Macario Reandelar Jr.
Philippine Journal of Ophthalmology 2013;38(2):72-79
Objective:
(1) To determine if preterm babies with ROP are missed with the existing Philippine Pediatric SocietyPhilippine Academy of Ophthalmology 2005 screening criteria of ≤32 weeks gestational age (GA) and ≤1,500
grams birth weight (BW), (2) to determine the incidence (missed-out rate) of these babies with ROP (>32 weeks
GA, >1,500 grams BW), (3) to describe their profile, and (4) to determine the appropriate upper limit for GA and
BW that can provide safe and efficient screening for severe ROP.
Methods:
This is a multicenter, retrospective cohort, observational study using data on ROP screening from the medical records of preterm babies from 4 institutions. All babies born ≤36 weeks GA, regardless of BW, who previously underwent ROP screening in 2011-2013, were included. Outcome measures were: (1) missed-out rate, (2) profile of missed babies with ROP (GA, BW, and risk factors), and (3) the proposed new criteria.
Results
Of the 762 babies screened, 105 (13.8%) had ROP. Of these, 13 (12%) had severe ROP, 28 (27%) was born at 33-36 weeks GA, and 32 (30%) with >1,500 grams BW. The oldest and heaviest of these missed babies with type 1 ROP was almost consistently reported at <35 weeks GA and <2,000 grams BW. Associated significant risk factors seen among missed babies were sepsis, respiratory distress syndrome (RDS), oxygen supplementation, and blood transfusion. There were 45 babies (43%) with ROP but with no risk factors. Among these were babies with GA >32 weeks and BW >1500 grams with ROP. The incidences of ROP, with and without risk factors, in the 4 institutions were not statistically significant. Seventeen (16.2%) preterm babies were missed with the existing criteria. Two of these had no risk factors but had type 1 and type 2 ROP. When <35 weeks GA and <2,000 grams BW as the new criteria were applied, the missed-out rate was reduced to 2% and was further reduced to zero with the inclusion of risk factors.
Retinopathy of Prematurity
;
Mass Screening